Hong Kong and Mainland Sign TCM Testing Cooperation Agreement in Beijing
RTHK · 2 SOURCESabout 5 hours ago5 MIN
Summary
Director of Health Lam Man-kin led a Health Department delegation to Beijing on Wednesday to meet with officials from the National Medical Products Administration (NMPA), signing a cooperation arrangement to deepen collaboration in Chinese medicine testing and international standardization efforts .
Key Points
- Director of Health Lam Man-kin (林文健) and NMPA's Office for Hong Kong, Macau and Taiwan Affairs Director He Li (何莉) signed the "Cooperation Arrangement on Chinese Medicine Testing and Standards Research"
- The agreement extends collaboration spanning more than a decade in Chinese medicine testing technologies and standards development
- Cooperation covers Chinese herbal materials, prepared slices, Chinese patent medicines, and concentrated granules — including standards research, testing technology development, and quality safety risk control
- The two sides will conduct exchanges through expert meetings, seminars, and training programs
- The Health Department was invited by the Beijing Municipal Health Commission to co-host the annual Beijing-Hong Kong Health Cooperation Exchange during this year's China International Fair for Trade in Services
- Lam stated the department will leverage its technical strengths in Chinese medicine testing and quality control to serve as a key support point for Chinese medicine going global
Why It Matters
The signing aligns with the nation's 15th Five-Year Plan's emphasis on advancing Traditional Chinese Medicine innovation and global reach, positioning Hong Kong's technical expertise in Chinese medicine quality control as an integral component of the "Healthy China" strategy while reinforcing Beijing-Hong Kong collaboration in an emerging strategic sector .
The signing aligns with the nation's 15th Five-Year Plan's emphasis on advancing Traditional Chinese Medicine innovation and global reach, positioning Hong Kong's technical expertise in Chinese medicine quality control as an integral component of the "Healthy China" strategy while reinforcing Beijing-Hong Kong collaboration in an emerging strategic sector .